Oligodendroglial neoplasms: Current concepts, misconceptions, and folklore

被引:49
作者
Perry, A [1 ]
机构
[1] Washington Univ, Sch Med, Div Neuropathol, St Louis, MO 63110 USA
关键词
glioma; oligodendroglioma; oligoastrocytoma; prognosis; tumor genetics;
D O I
10.1097/00125480-200107000-00001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Given current prognostic and therapeutic implications, the accurate classification and grading of oligodendroglial neoplasms has become critical. However, the prevalence of morphologically ambiguous gliomas, subjective histologic criteria, personal biases, oligodendroglioma mimics, and the lack of specific oligodendroglioma markers has led to high interobserver variability and created a contentious problem encountered daily in active surgical neuropathology practices. Since histologic assessment is still a powerful prognosticator, it appropriately remains the diagnostic gold standard. However, recent efforts have focused on identifying the most reproducible and clinically relevant criteria, standardizing classification and grading: schemes, and searching for useful ancillary biologic and genetic markers capable of further stratifying an otherwise heterogenous patient population. This paper reviews the morphologic and genetic spectrum of oligodendroglial neoplasms, recent diagnostic and prognostic developments, and potential future directions.
引用
收藏
页码:183 / 199
页数:17
相关论文
共 131 条
[1]  
ALDPE K, 2000, CANCER, V88, P2342
[2]  
[Anonymous], RESEARCH-CHINA, V47, P178, DOI [10.1177/0093650218777177, DOI 10.1177/0093650218777177, DOI 10.1177/106689699400200109]
[3]   Oligodendrogliomas of the brain. [J].
Bailey, P ;
Bucy, PC .
JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1929, 32 (04) :735-751
[4]   Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas [J].
Balesaria, S ;
Brock, C ;
Bower, M ;
Clark, J ;
Nicholson, SK ;
Lewis, P ;
de Sanctis, S ;
Evans, H ;
Peterson, D ;
Mendoza, N ;
Glaser, MG ;
Newlands, ES ;
Fisher, RA .
BRITISH JOURNAL OF CANCER, 1999, 81 (08) :1371-1377
[5]   Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas [J].
Bauman, GS ;
Ino, Y ;
Ueki, K ;
Zlatescu, MC ;
Fisher, BJ ;
Macdonald, DR ;
Stitt, L ;
Louis, DN ;
Cairncross, JG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03) :825-830
[6]   hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas [J].
Bello, MJ ;
de Campos, JM ;
Vaquero, J ;
Ruiz-Barnés, P ;
Kusak, ME ;
Sarasa, JL ;
Rey, JA .
CANCER GENETICS AND CYTOGENETICS, 2000, 116 (02) :142-147
[7]  
BELLO MJ, 1995, INT J CANCER, V64, P207
[8]  
BERGER MS, 1994, CANCER, V74, P1784, DOI 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO
[9]  
2-D
[10]  
Bigner S H, 1999, Neuro Oncol, V1, P52, DOI 10.1093/neuonc/1.1.52